BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioElectronics Corporation's ActiPatch® Musculoskeletal Pain Relief Nominated for "Most Innovative New OTC Product Award"


2/19/2013 12:50:34 PM

FREDERICK, Md., Feb. 19, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that its ActiPatch® Musculoskeletal Pain Relief Therapy product has received a nomination for the "Most Innovative New OTC Product Award" by the OTC Bulletin, the leading international trade publication for OTC developments worldwide.

The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries.

The Most Innovative New OTC Product Award is one of the prestigious awards that make up the 2013 OTC Marketing Awards. ActiPatch® Musculoskeletal Pain Relief Therapy and the nominees, Blistex Cold Sore Cream (Dendron), Nicorette Cools Lozenge (McNeil Products), Nurofen Express Soluble 400 mg Powder (Reckitt Benekiser), Voltarol 25mg Extra Strength Tablets (Novartis), and the Non-Contact Thermometer and the Repel Light Fragrance Once Lotion, (Boots Pharmaceuticals) were judged by a panel of six independent experts experienced and knowledgeable in the OTC market.

"We are excited to have been nominated for another prestigious award," said Ben Fichter, Marketing Manager. "We believe our products will continue to be recognized and awarded as an innovative, effective and safe therapy for relieving pain given that they provide 5x more effective pain relief than OTC drug therapy and costs less than $0.25 for eight hours of safe treatment."

The award presentation will take place on Thursday, March 7, 2013 in London, United Kingdom.

For more information, please visit www.otcbulletin.com/awards.

About BioElectronics Corporation
Drugs and heat patches provide temporary minimal pain relief by simply masking it but it always comes back. ActiPatch provides 5x better pain relief and is 100% safer than over-the-counter drugs. BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay menstrual cycle pain therapy, and RecoveryRx for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective in-home option to reduce soft tissue pain and inflammation, and to accelerate healing. For more information, please see www.bielcorp.com.

Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com

SOURCE BioElectronics Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES